Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.
4 reports, 1 independent
Updated Aug 30
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amylyx Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
-
Mizuho
city in Gifu prefecture, Japan
Nothing else this week.
-
Benzinga
American news channel
Related events
- Benzinga is reporting on stock price targets and earnings for Usio.
- Mizuho set a target price and Raymond James Financial cut the stock rating for Roper Technologies on September 10, 2026.
- Benzinga reported on the financial performance of UnitedHealth Group, while MarketBeat aggregated consensus ratings and target prices.
- Mizuho, Bank of America, and TD Cowen have issued rating and price target changes for Texas Instruments.
- Kimberly-Clark reported on analyst targets and earnings data.